학술논문
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG
Document Type
Article
Source
In: Pharmaceutics . (Pharmaceutics, March 2023, 15(3))
Subject
Language
English
ISSN
19994923